GLP-1 Semaglutide in New York: Buy Online for $99/Month
New York residents from Manhattan to Buffalo can access affordable compounded semaglutide through licensed telehealth.
New York State's high cost of living makes affordable healthcare more important than ever. Brand-name semaglutide (Wegovy) costs over $1,000/month, putting it out of reach for many New Yorkers. TRIMI offers compounded semaglutide for just $99/month -- from the five boroughs to Western New York, with no insurance required.
New York's GLP-1 Landscape
New York has robust telehealth and pharmacy regulations. The New York State Board of Pharmacy oversees compounding operations, ensuring quality and safety standards are met. The state's telehealth laws support virtual GLP-1 prescriptions.
New York at a Glance
- • Population: ~19.5 million residents
- • Obesity rate: ~28% of adults
- • Telehealth: Fully supported for GLP-1 prescriptions
- • Compounding: Regulated by NY Board of Pharmacy
- • Shipping: 3-5 day delivery statewide
Cost Comparison
| Option | Monthly Cost | Insurance Required |
|---|---|---|
| Wegovy (brand) | $1,000-$1,400 | Recommended |
| Ozempic (off-label) | $900-$1,200 | Recommended |
| TRIMI (compounded) | $99/month | No |
Access Across New York
- NYC (all five boroughs): Skip Manhattan clinic prices and long waitlists with virtual access
- Long Island: Convenient telehealth from Nassau and Suffolk counties
- Westchester & Hudson Valley: Suburban access without NYC commute
- Upstate (Albany, Syracuse, Rochester, Buffalo): Full coverage with fast delivery
- Rural New York: Equal access for Adirondacks, Catskills, and beyond
How to Get Started
Step 1: Consultation
Online assessment and virtual visit with a NY-licensed provider.
Step 2: Evaluation
Provider reviews BMI, health history, and creates your dosing plan.
Step 3: $99/Month
No insurance, no prior auth, no hidden fees. Cancel anytime.
Step 4: Delivery
Shipped to your New York address within 3-5 business days.
New York Insurance
New York has some of the strongest insurance regulations in the country, but GLP-1 coverage remains inconsistent. Many employer plans and NY State of Health marketplace plans require prior authorization for weight loss medications. TRIMI eliminates these barriers with straightforward $99/month pricing.
Medical Disclaimer
This article is for informational purposes only. Semaglutide requires evaluation by a licensed healthcare provider. Side effects may include nausea, vomiting, diarrhea, and constipation. Not suitable for individuals with MTC or MEN 2 history.
Ready to Start Semaglutide in New York?
Affordable GLP-1 treatment for all New Yorkers. Just $99/month with statewide shipping.
Get Started for $99/MonthMore on state guides
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).